Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-01-26FDA Approved: DUOPA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for DUOPA (carbidopa and levodopa) submitted by AbbVie Inc.
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: Duodopa Home Titration Using Telemedicine: Evaluation of Use of Resources
This clinical trial update reports on home titration of Duodopa (carbidopa/levodopa intestinal gel) for Parkinson's disease using telemedici…
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: Possible Use of Rotigotine in Subjects 70 Years and Older With Late Onset of Disease [Phase 2]
A Phase 2 study evaluating rotigotine for late-onset Parkinson's disease in subjects aged 70 years and older has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-01-21Clinical Trial Update: Effects of Rasagiline on Sleep Disturbances in Parkinson's Disease [Phase 4]
Phase 4 trial results evaluate the effects of rasagiline on sleep disturbances in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2016-01-21Clinical Trial Update: The Long Term Impact of Initiating Pramipexole Versus Levodopa in Early Parkinson's Disease (CALM-PD Cohort Study)
The CALM-PD cohort study comparing initiating pramipexole versus levodopa in early Parkinson's disease has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection Trial [Phase 2]
A Phase 2 neuroprotection trial for Parkinson's disease conducted by NINDS has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: The Effects of L-Tyrosine on 24 Hour Blood Pressure and Heart Rate in Parkinson's Disease [EARLY_Phase 1]
This early-phase trial examined the effects of L-Tyrosine on 24-hour blood pressure and heart rate in Parkinson's disease. The study status …
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Effects of Home Therapeutic Exercises Oriented for Patients With Parkinson's Disease [NA]
A completed clinical trial evaluating the effects of home-based therapeutic exercises for patients with Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). [Phase 3]
A Phase 3 trial evaluating IPX066 for advanced Parkinson's disease has completed with results posted in 2016.
-
CLINICAL_TRIALS research · 2016-01-14Clinical Trial Update: Pharmacokinetic Study in Healthy Volunteers [Phase 1]
Phase 1 pharmacokinetic study in healthy volunteers sponsored by Orion Corporation related to Parkinson's disease. The study status is compl…
-
CLINICAL_TRIALS trial_result · 2016-01-13Clinical Trial Update: Imaging Non-motor Symptoms of Parkinson's Disease by Novel 18F-DTBZ and Florbetapir F-18 PET [Phase 2]
Phase 2 trial update evaluating imaging biomarkers with 18F-DTBZ and Florbetapir F-18 PET to study non-motor symptoms in Parkinson's disease…
-
CLINICAL_TRIALS trial_result · 2016-01-13Clinical Trial Update: Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia [Phase 2]
This Phase 2 trial update reports efficacy and safety results for JM-010 in Parkinson's disease patients with levodopa-induced dyskinesia.
-
CLINICAL_TRIALS trial_result · 2016-01-13Clinical Trial Update: Efficacy and Safety of F-18 FPCIT PET in Parkinson's Disease and Essential Tremor Patients [Phase 3]
Phase 3 trial evaluating the efficacy and safety of the fluorine-18 FP-CIT PET tracer in patients with Parkinson's disease and essential tre…
-
CLINICAL_TRIALS research · 2016-01-12Clinical Trial Update: Ancillary Longitudinal CSF Collection Study in the Harvard Biomarker Study - HBS2
This entry describes an ancillary longitudinal cerebrospinal fluid collection study within the Harvard Biomarker Study (HBS2). It is sponsor…
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy Titration
A completed clinical trial evaluated an ambulatory dyskinesia monitor to aid drug therapy titration in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: Kinesia HomeView - Home Diary Comparison [NA]
Update on the Kinesia HomeView home diary trial in Parkinson's disease; the NCT01920425 study by Great Lakes NeuroTechnologies has completed…
-
CLINICAL_TRIALS trial_result · 2016-01-11Clinical Trial Update: Deep Brain Stimulation in HUCH Region Between 2006 and 2014
The clinical trial NCT02652104 evaluating deep brain stimulation for Parkinson's disease in the Helsinki and Uusimaa region was completed be…
-
CLINICAL_TRIALS trial_result · 2016-01-11Clinical Trial Update: Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices [NA]
A completed clinical trial evaluated the effectiveness of low-cost devices in improving patient adherence across multiple conditions. The up…
-
FDA approval · 2016-01-10FDA Approved: ROPINIROLE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for ropinirole submitted by Alembic Pharmaceuticals Limited (ANDA 202786).
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy [Phase 3]
Phase 3 study of droxidopa in symptomatic neurogenic orthostatic hypotension, including participants with Parkinson's disease, multiple syst…
-
CLINICAL_TRIALS research · 2016-01-08Clinical Trial Update: A Trial of Neurocognitive and Supportive Therapy Interventions for Individuals With Parkinson's Disease [NA]
An update on a completed study evaluating neurocognitive and supportive therapy interventions for people with Parkinson's disease. The study…
-
CLINICAL_TRIALS research · 2016-01-08Clinical Trial Update: Rhythmic Auditory Stimulation Optimalization for Gait Improvement in Parkinson's Disease - BeatPark Study [NA]
This document reports a clinical trial update for the BeatPark study evaluating rhythmic auditory stimulation to improve gait in Parkinson's…
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: Computer-based Cognitive Training for Individuals With Parkinson's Disease [NA]
A Virginia Commonwealth University–sponsored clinical trial evaluating computer-based cognitive training for individuals with Parkinson's di…
-
CLINICAL_TRIALS trial_result · 2015-12-31Clinical Trial Update: Mobilaser Study to Help With People Who Are Having Problems With Their Gait [EARLY_Phase 1]
A Mayo Clinic early-phase 1 trial evaluating Mobilaser for gait problems in Parkinson's disease and Parkinsonism has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-30Clinical Trial Update: Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-benefit [Phase 4]
Phase 4 trial evaluating the cost-benefit of continuous levodopa delivery in advanced Parkinson's disease has completed.